The conclusions are noteworthy, simply because a earlier randomized controlled trial in Kenya discovered that doxyPEP wasn't productive in protecting against bacterial STIs in cisgender Gals. Industry experts have prompt that those final results is likely to be attributed to lower adherence. With this examine, adherence was significant.We'll tell y